BISPECIFIC MOLECULE BINDING TLR9 AND CD32 AND COMPRISING A T CELL EPITOPE FOR TREATMENT OF ALLERGIES

Number of patents in Portfolio can not be more than 2000

United States of America Patent

SERIAL NO

12281504

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

A molecule or molecule complex capable of binding to TLR9 and to CD32 comprising at least one epitope of at least one antigen, its production and its use a medicament, especially for the treatment of allergies.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
S-TARGET THERAPEUTICS GMBH1190 VIENNA

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Himmler, Gottfried Vienna, AT 55 541
Mudde, Geert Wien, AT 16 82

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation